Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole

References

• Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J 2010;12:348–60.
   PubMed Web of Science ®Google Scholar
• Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems - recent advances. Prog Retin Eye Res 1998;17:33–58.
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Shaw J, Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv 2010;17:467–89.
   PubMed Web of Science ®Google Scholar
• Thrimawithana TR, Young S, Bunt CR, et al. Drug delivery to the posterior segment of the eye. Drug Discov Today 2011;16:270–7.
   PubMed Web of Science ®Google Scholar
• Kuno N, Fuji S. Recent advances in ocular drug delivery systems. Polymers 2011;3:193–221.
   Web of Science ®Google Scholar
• Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv Drug Deliv Rev 1993;11:349–83.
   Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13:144–51.
   PubMed Web of Science ®Google Scholar
• Bucolo C, Drago F, Salomone S. Ocular drug delivery: a clue from nanotechnology. Front Pharmacol 2012;3:188.
   PubMed Web of Science ®Google Scholar
• Singh H, Jindal S, Singh M, et al. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety. Int J Pharm 2015;485:138–51.
   PubMed Web of Science ®Google Scholar
• Kumar R, Sinha VR. Preparation and optimization of voriconazole microemulsion for ocular delivery. Colloids Surf B Biointerfaces 2014;117:82–8.
   PubMed Web of Science ®Google Scholar
• Souza JG, Dias K, Pereira TA, et al. Topical delivery of ocular therapeutics: carrier systems and physical methods. J Pharm Pharmacol 2014;66:507–30.
   PubMed Web of Science ®Google Scholar
• Li R, Jiang S, Liu D, et al. A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide. J Microencapsul 2011;28:134–41.
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kumar R, Pandit JK. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Eur J Pharm Sci 2012;47:678–85.
   PubMed Web of Science ®Google Scholar
• Puglia C, Offerta A, Carbone C, et al. Lipid nanocarriers (LNC) and their applications in ocular drug delivery. Curr Med Chem 2015;22:1589–602.
   PubMed Web of Science ®Google Scholar
• Carbone C, Cupri S, Leonardi A, et al. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization. Pharm Pat Anal 2013;2:665–77.
   PubMedGoogle Scholar
• Carbone C, Leonardi A, Cupri S, et al. Pharmaceutical and biomedical applications of lipid-based nanocarriers. Pharm Pat Anal 2014;3:199–215.
   PubMedGoogle Scholar
• Hippalgaonkar K, Adelli GR, Repka MA, Majumdar S. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther 2013;29:216–28.
   PubMed Web of Science ®Google Scholar
• Lutfi G, Müzeyyen D. Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application. Pharm Dev Technol 2013;18:701–9.
   PubMed Web of Science ®Google Scholar
• Seyfoddin A, Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug Dev Ind Pharm 2013;39:508–19.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang X, Wu H, et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 2011;37:475–81.
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sirmagul B, Yazan Y. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37–47.
   PubMed Web of Science ®Google Scholar
• Leonardi A, Bucolo C, Drago F, et al. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. Int J Pharm 2015;478:180–6.
   PubMed Web of Science ®Google Scholar
• Jeu LA, Piacenti FJ, Lyakhovetskiy AG, Fung HB. Voriconazole. Clin Ther 2003;25:1321–81.
   PubMed Web of Science ®Google Scholar
• Keadya S, Thacker M. Voriconazole in the treatment of invasive fungal infections. Intensive Crit Care Nurs 2005;21:370–3.
   PubMedGoogle Scholar
• Pappas PG. Immunotherapy for invasive fungal infections: from bench to bedside. Drug Resist Update 2004;7:3–10.
   PubMed Web of Science ®Google Scholar
• Myrianthefs P, Markantonis SL, Evaggelopoulou P, et al. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study. Int J Antimicrob Agents 2010;35:468–72.
   PubMed Web of Science ®Google Scholar
• Slowik M, Biernat MM, Urbaniak-Kujda D, et al. Adv Clin Exp Med 2015;24:1113–17.
   PubMed Web of Science ®Google Scholar
• Hector RF. An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals. Clin Tech Small Anim Pract 2005;20:240–9.
   PubMedGoogle Scholar
• Harrison TS, Brouwer AE. Systemic fungal infections. Medicine 2005;33:116–19.
   Google Scholar
• Soni N, Wagstaff A. Fungal infection. Curr Anaesth Crit Care 2005;16:231–41.
   Google Scholar
• Lat A, Thompson GR. Update on the optimal use of voriconazole for invasive fungal infections. Infect Drug Resist 2011;4:43–53.
   PubMedGoogle Scholar
• Di Domenico B. Novel antifungal drugs. Curr Opin Microbiol 1999;2:509–15.
   PubMed Web of Science ®Google Scholar
• Wiebe V, Karriker M. Therapy of systemic fungal infections: a pharmacologic perspective. Clin Tech Small Anim Pract 2005;20:250–7.
   PubMedGoogle Scholar
• Xu SX, Shen JL, Tang XF, Feng B. Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis. Transplant Proc 2013;45:407–14.
   Google Scholar
• Zaragoza R, Peman J. The diagnostic and therapeutic approach to fungal infections in critical care settings. Adv Sepsis 2008;6:90–8.
   Google Scholar
• Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004;820–5.
   PubMed Web of Science ®Google Scholar
• Al-Badriyeh D, Neoh CF, Stewart K, Kong DCM. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 2010;4:391–405.
   PubMedGoogle Scholar
• Gupta S, Shrivastava RM, Tandon R, et al. Role of voriconazole in combined acanthamoeba and fungal corneal ulcer. Cont Lens Anterior Eye 2011;34:287–9.
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163–71.
   PubMed Web of Science ®Google Scholar
• Sonawane R, Harde H, Katariya M, et al. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv 2014;11:1833–47.
   PubMed Web of Science ®Google Scholar
• Pegi A, Julijana K, Slavko P, et al. The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance. J Pharm Sci 2003;92:58–66.
   PubMed Web of Science ®Google Scholar
• Kashi TS, Eskandarion S, Esfandyari-Manesh M, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 2010;7:221–34.
   Web of Science ®Google Scholar
• Morrison PW, Khutoryanskiy VV. Enhancement in corneal permeability of riboflavin using calcium sequestering compounds. Int J Pharm 2014;472:56–64.
   PubMed Web of Science ®Google Scholar
• McKenzie B, Kay G, Matthews KH, et al. The hen's egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: quantification using Photoshop® and ImageJ. Int J Pharm 2015;490:1–8.
   PubMed Web of Science ®Google Scholar
• Lou J, Hu W, Tian R, et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles, Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Int J Nanomedicine 2014;9:2517–25.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Z, Zeng W, et al. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci 2014;62:115–23.
   PubMed Web of Science ®Google Scholar
• Radomska A, Dobrucki R. The use of some ingredients for microemulsion preparation containing retinol and its esters. Int J Pharm 2000;196:131–4.
   PubMed Web of Science ®Google Scholar
• Abul Kalam M, Sultana Y, Ali A, et al. Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J Biomed Mater Res A 2013;101:1828–36.
   PubMed Web of Science ®Google Scholar
• Montenegro L, Bucolo C, Puglisi G. Enhancer effects on in vitro corneal permeation of timolol and acyclovir. Pharmazie 2003;58:497–501.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine 2013;8:1921–33.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–96.
   PubMed Web of Science ®Google Scholar
• Shukla R, Gupta J, Shukla P, et al. Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis. RSC Adv 2015;5:69047–56.
   Web of Science ®Google Scholar
• Raslan MAE. Effect of some formulation variables on the entrapment efficiency and in vitro release of ketoprofen from ketoprofen niosomes. J Life Med 2013;1:15–22.
   Google Scholar
• Were LM, Bruce BD, Davidson PM, Weiss J. Size, stability, and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials. J Agric Food Chem 2003;51:8073–9.
   PubMed Web of Science ®Google Scholar
• Lim LT, Ah-kee EY, Collins CE. Common eye drops and their implications for pH measurements in the management of chemical eye injuries. Int J Ophthalmol 2014;7:1067–8.
   PubMed Web of Science ®Google Scholar
• Bergstro M. Synergistic effects in mixtures of an anionic and a cationic surfactant. Langmuir 2001;17:993–8.
   Web of Science ®Google Scholar
• Luan X, Skupin M, Siepmann J, Bodmeier R. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles. Int J Pharm 2006;324:168–75.
   PubMed Web of Science ®Google Scholar
• Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 2001;73:21–136.
   PubMed Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217–23.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33.
   PubMed Web of Science ®Google Scholar
• Hamalainen KM, Kontturi K, Auriola S, et al. Estimation of pore size and pore density of biomembranes from permeability measurements of polyethylene glycols using an effusion-like approach. J Control Release 1997;49:97–104.
   Web of Science ®Google Scholar
• Mohanty B, Majumdar DK, Mishra SK, et al. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol 2015;20:458–64.
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kumar R, Dhanawat M, et al. Nanocrystal technology in the delivery of poorly soluble drugs: an overview. Curr Drug Deliv 2011;8:398–406.
   PubMed Web of Science ®Google Scholar
• Joo HH, Lee HY, Kim JC, et al. Integrities and skin permeation-enhancing characteristics of behenic acid nanoparticles. J Dispers Sci Technol 2009;30:149–54.
   Web of Science ®Google Scholar
• Bhatia KS, Singh J. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J Pharm Sci 1998;87:462–9.
   PubMed Web of Science ®Google Scholar
• Saettone MF, Cheton P, Cerbai R, et al. Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int J Pharm 1996;142:103–13.
   Web of Science ®Google Scholar
• Monti D, Chetoni P, Burgalassi S, et al. Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm 2002;232:139–47.
   PubMed Web of Science ®Google Scholar
• Emami J. In vitro-in vivo correlation: from theory to applications. J Pharm Pharm Sci 2006;9:169–89.
   Google Scholar